Form 4: TransMedics Group Executive Nicholas Corcoran Executes Stock Options and Sells Shares

Nicholas Corcoran, SVP of Supply Chain and Operations at TransMedics Group, exercised stock options and sold 10,000 shares of common stock on August 27, 2024.

Summary

• On August 27, 2024, Nicholas Corcoran, SVP of Supply Chain and Operations at TransMedics Group, exercised stock options to acquire 7,810 shares at $66.10 and 2,190 shares at $83.14.
• Corcoran then sold 10,000 shares of common stock at a weighted average price of $176.02, with individual transactions ranging from $176.00 to $176.33.
• Following these transactions, Corcoran directly owns 21,105 shares of TransMedics Group common stock.
• Corcoran also holds options to purchase 11,922 shares at $66.10 and 15,442 shares at $83.14.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Insider transactions are a normal part of corporate governance and are regularly disclosed by executives at companies like Medtronic, Boston Scientific, and Abbott Laboratories.
• The size and frequency of these transactions are typical for executives holding stock options and equity in their companies.

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it represents a small percentage of the total outstanding shares.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates